EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment era

Minkyeong Lee iD, Byoung Kwon Park, Dong Hoon Shin iD, Hong Sang Oh, Chae-Hong Jeong, So-Young Lee, Jungyeon Kim, Sang-Won Park iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Minkyeong Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine & Boramae Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Disease Control and Prevention Agency’s research and development project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

During the COVID-19 endemic phase, pulmonary sequelae substantially contributed to disease burden. Immunologic responses may be critical in both acute COVID-19 and in long-term sequelae. We aimed to evaluate associations between convalescent neutralizing antibodies and long-term pulmonary sequelae in patients hospitalized with mild to moderate COVID-19.

Methods

Among patients who recovered from hospitalization due to COVID-19, those who consented to participate in the study provided convalescent serum between June 2021 and April 2022. These baseline patients were invited for a second follow-up visit between September and November 2023. A serum sample was collected at the second visit, and low-dose chest computed tomography (CT) was performed. Pulmonary sequelae were defined as findings of fibrotic, fibrotic-like, and ground-glass opacities (GGOs). Antibody and cytokine levels were assessed in serum samples from the baseline convalescent phase, and antibody levels were also measured in the serum sample at the second visit.

Results

A total of 107 patients were enrolled at baseline, and 37 consented to the second follow-up visit. Most second-visit patients (97.3%, 36/37) did not require an oxygen supply beyond that provided via masks or nasal prongs. Twenty-two patients (59.5%) exhibited pulmonary sequelae on chest CT at a median follow-up period of 27 months (interquartile range 25–28, range 22−30) after hospitalization for COVID-19. Fifteen patients (40.5%) had fibrotic or fibrotic-like pulmonary changes, and twelve (32.4%) had GGOs. Pulmonary sequelae were associated with older age (adjusted odds ratio 1.130, 95% confidence interval 1.028–1.243; P = 0.011). There were no significant differences in convalescent cytokines or neutralizing antibodies between patients with pulmonary sequelae and those without.

Conclusion

Pulmonary sequelae were quite common on chest CT after two years of mild to moderate COVID-19 and were associated with older age. The immunological or inflammatory status in the immediate post-acute infection period did not predict long-term complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansMaleFemaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralSARS-CoV-2AgedTomography, X-Ray ComputedLungAdultCOVID-19 SerotherapyHospitalizationCytokinesImmunization, PassivePulmonary Fibrosis

Substanzen

Antibodies, NeutralizingAntibodies, ViralCytokines

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine & Boramae Medical Center, Seoul, Republic of Korea.
  • Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.

ORCID-Profile: Minkyeong Lee, Dong Hoon Shin, Sang-Won Park

Förderung

  • Korea Disease Control and Prevention Agency’s research and development project

Zitieren

APA

Lee, M., Park, B. K., Shin, D. H., Oh, H. S., Jeong, C. H., Lee, S. Y., Kim, J., & Park, S. W. (2025). Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment era. PLOS One. https://doi.org/10.1371/journal.pone.0325379

Vancouver

Lee M, Park BK, Shin DH, Oh HS, Jeong CH, Lee SY, et al. Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment era. PLOS One. 2025. doi:10.1371/journal.pone.0325379

BibTeX
@article{Lee2025,
  author = {Lee, Minkyeong and Park, Byoung Kwon and Shin, Dong Hoon and Oh, Hong Sang and Jeong, Chae-Hong and Lee, So-Young and Kim, Jungyeon and Park, Sang-Won},
  title = {Long-term pulmonary sequelae and convalescent immune reactions in mild to moderate COVID-19 patients during the active treatment era},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325379}
}
Kostenlos starten →